[Duration of antibiotic therapy for common respiratory infections in adults]

Catia Vieira Gomes1, Frank Bally1

  • 1Service des maladies infectieuses, Institut central des hôpitaux, 1951 Sion.

Revue Medicale Suisse
|October 11, 2023
PubMed

Insights

For most adult respiratory infections, antibiotics aren't needed. Shorter antibiotic courses, like 5-7 days for specific infections, are now recommended when treatment is necessary, minimizing risks and costs.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Public Health

Background:

  • Respiratory tract infections (RTIs) are common in adult outpatients.
  • Antibiotic overuse contributes to resistance and side effects.
  • Optimizing antibiotic duration is crucial for patient outcomes and healthcare costs.

Approach:

  • Literature review of current evidence and guidelines.
  • Synthesis of recommendations for antibiotic treatment durations.
  • Focus on common outpatient RTIs including pneumonia, COPD exacerbation, otitis media, pharyngitis, and sinusitis.

Key Points:

  • Antibiotic therapy is generally not indicated for most adult outpatient RTIs.
  • Shorter antibiotic courses are recommended when treatment is mandatory.
  • Specific recommended durations: 5 days for community-acquired pneumonia, COPD exacerbation, and acute otitis media; 6 days for pharyngitis; 5-7 days for sinusitis.

Conclusions:

  • Shorter antibiotic durations are evidence-based for common RTIs in adults.
  • These shorter regimens help mitigate antibiotic resistance, side effects, and healthcare expenses.
  • Exclusions apply to severe/complicated infections, resistant organisms, and immunocompromised patients.

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
184
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
462
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
350
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
602
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
144
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
218